Synergy in Cystic Fibrosis Therapies: Targeting SLC26A9
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms222313064
Abstract: SLC26A9, a constitutively active Cl− transporter, has gained interest over the past years as a relevant disease modifier in several respiratory disorders including Cystic Fibrosis (CF), asthma, and non-CF bronchiectasis. SLC26A9 contributes to epithelial Cl−… read more here.
Keywords: cystic fibrosis; expression; cftr; f508del cftr ... See more keywords
Expression of SLC26A9 in Airways and Its Potential Role in Asthma
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23062998
Abstract: SLC26A9 is an epithelial anion transporter with a poorly defined function in airways. It is assumed to contribute to airway chloride secretion and airway surface hydration. However, immunohistochemistry showing precise localization of SLC26A9 in airways… read more here.
Keywords: localization; cftr; slc26a9; slc26a9 airways ... See more keywords